ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
21.732,05
0,01%
S&P 500
6.040,53
-0,50%
Dow Jones
44.544,66
-0,75%
Euro vs US Dollar
1,0366
0,04%
Bitcoin
100.262,28
-0,40%
Pepperstone
Advertisement
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. Verrica Parmaceuticals Inc (VRCA) Börsenkurse

Verrica Parmaceuticals Inc

Verrica Parmaceuticals Inc (VRCA)

NASDAQ
0,6476
-0,0696
(-9,70%)
Geschlossen 02 Februar 10:00PM
Verzögert um 15 Minuten
0,6478
0,0002
(0,03%)
Nach Börsenschluss: 1:35AM
Verzögert um 15 Minuten

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Wichtige Statistiken und Details

Current Price
0,6478
Gebot
0,6478
Fragen
0,732
Volumen
289.651
0,63 Tagesbereich 0,7338
0,6109 52-Wochen-Bereich 11,41
Marktkapitalisierung
29,54M
Handelsende
0,7172
Handelsbeginn
0,7338
Letzte Trade
215
@
0.6478
(formt)
Letzter Handelszeitpunkt
Finanzvolumen
US$ 193.825
VWAP
0,669167
Durchschnittliches Volumen (3 Mio.)
636.506
Ausgegebene Aktien
45.600.795
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,44
Gewinn pro Aktie (EPS)
-1,47
Erlöse
5,12M
Nettogewinn
-67M

Über Verrica Parmaceuticals Inc

Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its lead product candidate, VP-102, is developed for the treatment of molluscum contagiosum, ... Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its lead product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a highly contagious and primarily pediatric viral skin disease, and common warts. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
www.verrica.com
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Verrica Parmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker VRCA. The last closing price for Verrica Parmaceuticals was US$0,72. Over the last year, Verrica Parmaceuticals shares have traded in a share price range of US$ 0,6109 to US$ 11,41.

Verrica Parmaceuticals currently has 45.600.795 shares in issue. The market capitalisation of Verrica Parmaceuticals is US$32,70 million. Verrica Parmaceuticals has a price to earnings ratio (PE ratio) of -0.44.

VRCA Neueste Nachrichten

Weitere Nachrichten

Form 8-K - Current report

30 Januar 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

09 Dezember 2024
Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities

09 Dezember 2024
Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans

09 Dezember 2024
Edgar (US Regulatory)

Form 8-K - Current report

09 Dezember 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

26 November 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

26 November 2024
Edgar (US Regulatory)

Form 8-K - Current report

21 November 2024
Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]

21 November 2024
Edgar (US Regulatory)

Form 8-K - Current report

20 November 2024
Edgar (US Regulatory)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.0665-9.309813803720.71430.74780.6421346310.72034932CS
4-0.0616-8.683394417820.70940.760.62013221950.69254207CS
12-0.068-9.499860296170.71581.360.61096365060.87016117CS
26-6.1222-90.43131462336.777.10.61098358031.68632121CS
52-4.9822-88.49378330375.6311.410.61095117522.70070013CS
156-6.8822-91.39707835337.5311.410.61094005234.06734495CS
260-13.8422-95.529330572814.4918.420.61092799125.04775261CS

VRCA - Frequently Asked Questions (FAQ)

What is the current Verrica Parmaceuticals share price?
The current share price of Verrica Parmaceuticals is US$ 0,6478
How many Verrica Parmaceuticals shares are in issue?
Verrica Parmaceuticals has 45.600.795 shares in issue
What is the market cap of Verrica Parmaceuticals?
The market capitalisation of Verrica Parmaceuticals is USD 32,7M
What is the 1 year trading range for Verrica Parmaceuticals share price?
Verrica Parmaceuticals has traded in the range of US$ 0,6109 to US$ 11,41 during the past year
What is the PE ratio of Verrica Parmaceuticals?
The price to earnings ratio of Verrica Parmaceuticals is -0,44
What is the cash to sales ratio of Verrica Parmaceuticals?
The cash to sales ratio of Verrica Parmaceuticals is 5,78
What is the reporting currency for Verrica Parmaceuticals?
Verrica Parmaceuticals reports financial results in USD
What is the latest annual turnover for Verrica Parmaceuticals?
The latest annual turnover of Verrica Parmaceuticals is USD 5,12M
What is the latest annual profit for Verrica Parmaceuticals?
The latest annual profit of Verrica Parmaceuticals is USD -67M
What is the registered address of Verrica Parmaceuticals?
The registered address for Verrica Parmaceuticals is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Verrica Parmaceuticals website address?
The website address for Verrica Parmaceuticals is www.verrica.com
Which industry sector does Verrica Parmaceuticals operate in?
Verrica Parmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
TCTMTCTM Kids IT Education Inc
US$ 0,764
(321,87%)
729,72M
REBNReborn Coffee Inc
US$ 3,31
(63,05%)
55,54M
FCUVFocus Universal Inc
US$ 5,87
(56,62%)
1,73M
SOPASociety Pass Inc
US$ 1,54
(56,50%)
13,82M
CYCNCyclerion Therapeutics Inc
US$ 3,92
(54,33%)
82,39M
ENVBEnveric Biosciences Inc
US$ 2,0899
(-46,41%)
1,57M
NIVFNewGenIvf Group Ltd
US$ 0,1489
(-42,51%)
14,8M
GLSTGlobal Star Acquisition Inc
US$ 8,83
(-39,10%)
23,89k
PRPHProPhase Labs Inc
US$ 0,2633
(-38,02%)
872,46k
SPGCSacks Parente Golf Inc
US$ 0,5601
(-37,86%)
7,27M
TCTMTCTM Kids IT Education Inc
US$ 0,764
(321,87%)
729,72M
NVDANVIDIA Corporation
US$ 120,07
(-3,67%)
388,54M
RIMEAlgorhythm Holdings Inc
US$ 0,02565
(5,12%)
338,75M
BHATBlue Hat Interactive Entertainment Technology
US$ 0,0355
(-11,25%)
236,29M
CLEUChina Liberal Education Holdings Ltd
US$ 0,1938
(30,77%)
234,8M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
VRCA
Verrica Parmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten

Werbung entfernen

Melden Sie sich für ein werbefreies Erlebnis an

Keine Werbung

Versuchen Sie es jetzt

Anzeigen behalten